Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
capecitabine (xeloda) (1 trial)
docetaxel (taxotere) (1 trial)
paclitaxel (taxol) (1 trial)
rc48-adc (1 trial)
vinorelbine (navelbine) (1 trial)
benfluorex (1 trial)
sitagliptin (januvia) (1 trial)
neural progenitor cell (1 trial)
paracrine factor of human mesenchymal stem cells (1 trial)
paracrine factors (1 trial)
progenitor cell (1 trial)
Breast Neoplasms (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2)
Trials (3 total)
Trial APIs (11 total)